SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$24.93
+4.88%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$24.00
From 52W high+0.00%
Volume1.29M
Market cap$1.12B
P/E (TTM)—
P/S (TTM)5.1x
Div yield—
Key dataNov 4, 2026
Open
$24.00
From 52W high
+0.00%
Volume
1.29M
Market cap
$1.12B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−261.4x
P/E (TTM)
—
RSI (14)
72.3
MomentumView details →
1D Return
+4.88%
YTD Return
+27.33%
SummaryUpdated Sep 1, 2026
SI-BONE, Inc. (NASDAQ:SIBN) is a medical device company founded in 2008 and headquartered in Santa Clara, California. The company went public in October 2018 and specializes in developing and commercializing implantable devices that address musculoskeletal disorders of the sacropelvic anatomy. What began as a single-product company focused on sacroiliac joint dysfunction has evolved into a multi-modality medical device platform targeting various conditions affecting the sacropelvic region, including adult spinal deformity, pelvic trauma, and related orthopedic conditions.
Similar companies
Latest newsMore news →
SI-BONE reported third-quarter 2026 revenue of $55.7 million, up 14.5% year over year, and a net loss of $3.6 million, or $0.08 per diluted share.2d agoSI-BONE announced that it will report third-quarter 2026 financial results after market close on November 2, 2026.16d agoSI-BONE, Inc. amended its lease with BIXBY SPE FINANCE 11, LLC, extending the term by one month to October 31, 2026 at a base rent of $43,696.00 per month.54d ago